捕获全长PDK1的构造转换,这些转换决定了酶基质选择性
Laura Martínez-Arenas1, Jose R Bayascas1
1Institut de Neurociències and Departament de Bioquímica i Biologia Molecular, Facultat de Medicina, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.
Science signaling
|June 13, 2023
概括
酸激酶M2 (PKM2) 是细胞代谢的关键调节剂,也是癌症治疗的目标. 这项研究揭示了PKM2活性是如何通过全调节控制的,为药物开发提供了新的见解.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 细胞信号传输 细胞信号传输
背景情况:
- PDK1 (3-酸依赖性酶-1) 是一个关键的酶,调节许多AGC家族酶.
- PDK1的构成性活动和广泛的基质特异性在理解其在细胞信号通路中的精确作用方面提出了挑战.
研究的目的:
- 阐明PDK1实现基质选择性的机制.
- 调查体通信在将PDK1活动引导到特定基质中的作用.
主要方法:
- 该研究采用了生物化学分析和结构生物学技术的组合.
- 分析的重点是PDK1.1不同功能域之间的相互作用.
主要成果:
- 萨克罗蒂和其他人 Sacerdoti等 证明PDK1域之间的基通讯对基质识别至关重要.
- 这种通信机制允许PDK1优先化其已知的24种AGC激酶基质的不同子集.
结论:
- 这些发现揭示了PDK1活动的新型调节层,解释了其基质选择性.
- 了解这种全性控制机制为在其活性失调的疾病中准PDK1提供了新的途径.
相关概念视频
Protein Kinases and Phosphatases
13.2K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.2K
Induced-fit Model
81.2K
Most chemical reactions in cells require enzymes—biological catalysts that speed up the reaction without being consumed or permanently changed. They reduce the activation energy needed to convert the reactants into products. Enzymes are proteins, that usually work by binding to a substrate—a reactant molecule that they act upon.
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
81.2K
Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
Receptor Tyrosine Kinases
13.2K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
13.2K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K


